OGN:NYSE
Organon & Co
US$13.88
arrow_downward
-0.07%(-0.010) 1D
ኖቬም 11, 3:24:43 ከሰዓት ጂ ኤም ቲ-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for OGN...
Open
US$13.89
High
US$13.89
Low
US$13.86
Mkt. cap
3.64 ቢ
Avg. vol.
2.44 ሚ
Volume
1.20 ሚ
Dividend
0.58%
Quarterly dividend
US$0.02
Ex-dividend date
14 ኦገስ 2026
P/E ratio
18.05
52-wk high
US$13.89
52-wk low
US$5.69
EPS
US$0.77
Beta
1.53
Shares outstanding
262.62 ሚ
No. of employees
10 ሺ
Open
US$13.89
High
US$13.89
Low
US$13.86
Mkt. cap
3.64 ቢ
Avg. vol.
2.44 ሚ
Volume
1.20 ሚ
Dividend
0.58%
Quarterly dividend
US$0.02
Ex-dividend date
14 ኦገስ 2026
P/E ratio
18.05
52-wk high
US$13.89
52-wk low
US$5.69
EPS
US$0.77
Beta
1.53
Shares outstanding
262.62 ሚ
No. of employees
10 ሺ
News stories
From web sources and news partners
Investing.com
·
ከ9 ሰዓቶች በፊት
how InvestingPro’s fair value spotted Organon’s 72% healthcare gain By Investing.com
Investing.com Canada
·
ከ23 ሰዓቶች በፊት
Organon & Co stock hits 52-week high at 13.89 USD
Yahoo Finance
·
ከ1 ቀን በፊት
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know
Profile
Organon & Co. is an American pharmaceutical company originally founded in Oss, The Netherlands and now headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States. Wikipedia
About Organon & Co
CEO-
Employees10 ሺ
Founded1923
HeadquartersJersey City, ኒው ጄርዚ, ዩናይትድ ስቴትስ
SectorHealth Care
IndustryPharmaceutical industry
Websiteorganon.com